Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
Protein

Endogenous retrovirus group K member 7 Env polyprotein

Gene

env

Organism
Human immunodeficiency virus 1
Status
Unreviewed-Annotation score: Annotation score: 3 out of 5-Experimental evidence at protein leveli

Functioni

Sites

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Binding sitei61 – 611MannoseCombined sources

GO - Molecular functioni

GO - Biological processi

Complete GO annotation...

Keywords - Biological processi

ApoptosisSAAS annotation, Fusion of virus membrane with host membraneSAAS annotation, Host-virus interaction, Viral attachment to host cellSAAS annotation, Viral penetration into host cytoplasm, Virus entry into host cell

Names & Taxonomyi

Protein namesi
Recommended name:
Endogenous retrovirus group K member 7 Env polyproteinSAAS annotation
Alternative name(s):
Endogenous retrovirus group K member 113 Env polyproteinSAAS annotation
Endogenous retrovirus group K member 13-1 Env polyproteinSAAS annotation
Endogenous retrovirus group K member 18 Env polyproteinSAAS annotation
Endogenous retrovirus group K member 19 Env polyproteinSAAS annotation
Endogenous retrovirus group K member 21 Env polyproteinSAAS annotation
Endogenous retrovirus group K member 24 Env polyproteinSAAS annotation
Endogenous retrovirus group K member 25 Env polyproteinSAAS annotation
Endogenous retrovirus group K member 6 Env polyproteinSAAS annotation
Endogenous retrovirus group K member 8 Env polyproteinSAAS annotation
Endogenous retrovirus group K member 9 Env polyproteinSAAS annotation
Envelope glycoprotein gp160SAAS annotation
Gene namesi
Name:envImported
OrganismiHuman immunodeficiency virus 1Imported
Taxonomic identifieri11676 [NCBI]
Taxonomic lineageiVirusesRetro-transcribing virusesRetroviridaeOrthoretrovirinaeLentivirusPrimate lentivirus group
Virus hostiHomo sapiens (Human) [TaxID: 9606]

Subcellular locationi

Topology

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Transmembranei20 – 4122HelicalSequence analysisAdd
BLAST
Transmembranei506 – 52924HelicalSequence analysisAdd
BLAST
Transmembranei672 – 69928HelicalSequence analysisAdd
BLAST

GO - Cellular componenti

Complete GO annotation...

Keywords - Cellular componenti

Host cell membraneSAAS annotation, Host endosomeSAAS annotation, Host membrane, Membrane, Viral envelope proteinUniRule annotationSAAS annotation, Virion

PTM / Processingi

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Disulfide bondi53 ↔ 73Combined sources
Glycosylationi87 – 871N-linked (GlcNAc...)Combined sourcesCAR_5006776414
Disulfide bondi118 ↔ 207Combined sources
Glycosylationi160 – 1601N-linked (GlcNAc...)Combined sourcesCAR_5006776412
Glycosylationi188 – 1881N-linked (GlcNAc...)Combined sourcesCAR_5006776415
Disulfide bondi220 ↔ 249Combined sources
Disulfide bondi230 ↔ 241Combined sources
Glycosylationi236 – 2361N-linked (GlcNAc...)Combined sourcesCAR_5006776405
Glycosylationi243 – 2431N-linked (GlcNAc...)Combined sourcesCAR_5006776408
Glycosylationi264 – 2641N-linked (GlcNAc...)Combined sourcesCAR_5006776407
Glycosylationi278 – 2781N-linked (GlcNAc...)Combined sourcesCAR_5006776409
Glycosylationi291 – 2911N-linked (GlcNAc...)Combined sourcesCAR_5006776410
Glycosylationi297 – 2971N-linked (GlcNAc...)Combined sourcesCAR_5006776416
Disulfide bondi298 ↔ 332Combined sources
Disulfide bondi332 ↔ 412Combined sources
Disulfide bondi332 ↔ 385Combined sources
Glycosylationi335 – 3351N-linked (GlcNAc...)Combined sourcesCAR_5006776411
Glycosylationi356 – 3561N-linked (GlcNAc...)Combined sourcesCAR_5006776413
Disulfide bondi378 ↔ 439Combined sources
Disulfide bondi385 ↔ 412Combined sources
Glycosylationi386 – 3861N-linked (GlcNAc...)Combined sourcesCAR_5006776403
Glycosylationi392 – 3921N-linked (GlcNAc...)Combined sourcesCAR_5006776406
Disulfide bondi395 ↔ 404Combined sources
Glycosylationi442 – 4421N-linked (GlcNAc...)Combined sourcesCAR_5006776404

Keywords - PTMi

Disulfide bondSAAS annotation

Structurei

3D structure databases

Select the link destinations:
PDBei
RCSB PDBi
PDBji
Links Updated
EntryMethodResolution (Å)ChainPositionsPDBsum
3NGBX-ray2.68A/D/G/I43-122[»]
A/D/G/I201-303[»]
A/D/G/I325-486[»]
3SE8X-ray1.90G43-486[»]
3SE9X-ray2.00G43-486[»]
3TGTX-ray1.90A43-486[»]
3U7YX-ray2.45G43-122[»]
G201-303[»]
G325-486[»]
4DKOX-ray1.98A/C43-486[»]
4DKPX-ray1.80A/C43-486[»]
4DKQX-ray1.89A43-486[»]
4DKRX-ray1.80A/C43-486[»]
4DKUX-ray2.49A/B43-122[»]
A/B201-303[»]
A/B325-486[»]
4DKVX-ray2.18A/B43-122[»]
A/B201-303[»]
A/B325-486[»]
4DVSX-ray2.10A/B43-122[»]
A/B201-303[»]
A/B325-486[»]
4DVTX-ray2.40A/B88-122[»]
A/B201-241[»]
A/B293-433[»]
A/B457-486[»]
4DVVX-ray1.94A/B88-122[»]
A/B201-433[»]
A/B457-486[»]
4DVWX-ray2.20A/B88-122[»]
A/B201-433[»]
A/B457-486[»]
4DVXX-ray2.40A/B88-122[»]
A/B201-433[»]
A/B457-486[»]
4H8WX-ray1.85G43-486[»]
4I54X-ray2.50A/B43-486[»]
4JB9X-ray2.60G43-486[»]
4JDTX-ray3.26G43-486[»]
4JKPX-ray2.82G43-486[»]
4JPVX-ray2.83G43-486[»]
4JPWX-ray2.90G43-486[»]
4LSPX-ray2.15G43-486[»]
4LSQX-ray2.25G43-486[»]
4LSRX-ray2.28G43-486[»]
4LSUX-ray2.30G43-486[»]
4OLUX-ray2.20G43-122[»]
G201-303[»]
G325-486[»]
4OLVX-ray2.50G43-122[»]
G201-303[»]
G325-486[»]
4OLWX-ray2.71G43-122[»]
G201-303[»]
G325-486[»]
4OLXX-ray2.20G43-122[»]
G201-303[»]
G325-486[»]
4OLYX-ray2.35G43-122[»]
G201-303[»]
G325-486[»]
4OLZX-ray2.10G43-122[»]
G201-303[»]
G325-486[»]
4OM0X-ray2.29G43-122[»]
G201-303[»]
G325-486[»]
4OM1X-ray2.13G43-122[»]
G201-303[»]
G325-486[»]
4P9HX-ray3.00G43-122[»]
G201-303[»]
G325-486[»]
4RFNX-ray3.21A/G43-486[»]
4RFOX-ray3.20G43-486[»]
4RZ8X-ray1.90A/B/C/D43-122[»]
A/B/C/D201-303[»]
A/B/C/D325-486[»]
4XNZX-ray3.39A/D/G43-122[»]
A/D/G201-303[»]
A/D/G325-486[»]
4XVTX-ray1.69G43-486[»]
4YDJX-ray2.31G/I43-122[»]
G/I201-303[»]
G/I325-486[»]
4YDKX-ray2.05G43-122[»]
G201-303[»]
G325-486[»]
4YDLX-ray1.80A/G43-122[»]
A/G201-303[»]
A/G325-486[»]
4YFLX-ray3.39E/G43-122[»]
E/G201-303[»]
E/G325-486[»]
ModBaseiSearch...
MobiDBiSearch...

Family & Domainsi

Domains and Repeats

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Domaini33 – 140108GP120InterPro annotationAdd
BLAST
Domaini141 – 505365GP120InterPro annotationAdd
BLAST
Domaini524 – 715192GP41InterPro annotationAdd
BLAST

Keywords - Domaini

Transmembrane, Transmembrane helixSequence analysisSAAS annotation

Family and domain databases

Gene3Di2.170.40.20. 2 hits.
InterProiIPR000777. HIV1_GP160.
IPR000328. Retroviral_envelope_protein.
[Graphical view]
PfamiPF00516. GP120. 2 hits.
PF00517. GP41. 1 hit.
[Graphical view]
SUPFAMiSSF56502. SSF56502. 2 hits.

Sequencei

Sequence statusi: Complete.

Q0ED31-1 [UniParc]FASTAAdd to basket

« Hide

        10         20         30         40         50
MRVKETQMNW PNLWKWGTLI LGLVIICSAS DNLWVTVYYG VPVWKDADTT
60 70 80 90 100
LFCASDAKAH ETEVHNVWAT HACVPTDPNP QEIHLENVTE NFNMWKNNMV
110 120 130 140 150
EQMQEDVISL WDQSLQPCVK LTPLCVTLHC TTAKLTNVTN ITNVPNIGNI
160 170 180 190 200
TDEVRNCSFN MTTEIRDKKQ KVHALFYKLD IVQIEDKNDS SKYRLINCNT
210 220 230 240 250
SVIKQACPKI SFDPIPIHYC TPAGYVILKC NDKNFNGTGP CKNVSSVQCT
260 270 280 290 300
HGIKPVVSTQ LLLNGSLAEE EIIIRSENLT NNAKTIIVHL NKSVEINCTR
310 320 330 340 350
PSNNMRTSMR IGPGQVFYRT GSITGDIRKA YCEINGTKWN KVLKQVTEKL
360 370 380 390 400
KEHFNNKTII FQPPSGGDLE ITMHHFNCRG EFFYCNTTQL FNNTCIGNET
410 420 430 440 450
MKGCNGTITL PCKIKQIINM WQGTGQAMYA PPIDGKINCV SNITGILLTR
460 470 480 490 500
DGGANNTSNE TFRPGGGNIK DNWRSELYKY KVVQIEPLGI APTRAKRRVV
510 520 530 540 550
EREKRAVGIG AMIFGFLGAA GSTMGAASIT LTVQARQLLS GIVQQQSNLL
560 570 580 590 600
RAIEAQQHLL QLTVWGIKQL QARVLAVERY LKDQKFLGLW GCSGKIICTT
610 620 630 640 650
AVPWNSTWSN KSFEEIWNNM TWIEWEREIS NYTNQIYEIL TESQNQQDRN
660 670 680 690 700
EKDLLELDKW ASLWNWFDIT NWLWYIKIFI MIVGGLIGLR IIFAVLSIVN
710 720 730 740 750
RVRQGYSPLS FQTPIHHQRE PDRPERIEEG GGEQGRDRSV RLVSGFLSLA
760 770 780 790 800
WDDLRSLCLF SYHRLRDFIL IATRTVELLG HSSLKGLRRG WEGLKYLGNL
810 820 830 840 850
LLYWGQELKI SAISLLNTTA IAVAGWTDRV IEVAQGAWRA ILHIPRRIRQ

GLERTLL
Length:857
Mass (Da):97,310
Last modified:October 17, 2006 - v1
Checksum:iAA83C4FF189CCD0E
GO

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
AB253424 Genomic DNA. Translation: BAF31367.1.
AB253425 Genomic DNA. Translation: BAF31376.1.

Cross-referencesi

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
AB253424 Genomic DNA. Translation: BAF31367.1.
AB253425 Genomic DNA. Translation: BAF31376.1.

3D structure databases

Select the link destinations:
PDBei
RCSB PDBi
PDBji
Links Updated
EntryMethodResolution (Å)ChainPositionsPDBsum
3NGBX-ray2.68A/D/G/I43-122[»]
A/D/G/I201-303[»]
A/D/G/I325-486[»]
3SE8X-ray1.90G43-486[»]
3SE9X-ray2.00G43-486[»]
3TGTX-ray1.90A43-486[»]
3U7YX-ray2.45G43-122[»]
G201-303[»]
G325-486[»]
4DKOX-ray1.98A/C43-486[»]
4DKPX-ray1.80A/C43-486[»]
4DKQX-ray1.89A43-486[»]
4DKRX-ray1.80A/C43-486[»]
4DKUX-ray2.49A/B43-122[»]
A/B201-303[»]
A/B325-486[»]
4DKVX-ray2.18A/B43-122[»]
A/B201-303[»]
A/B325-486[»]
4DVSX-ray2.10A/B43-122[»]
A/B201-303[»]
A/B325-486[»]
4DVTX-ray2.40A/B88-122[»]
A/B201-241[»]
A/B293-433[»]
A/B457-486[»]
4DVVX-ray1.94A/B88-122[»]
A/B201-433[»]
A/B457-486[»]
4DVWX-ray2.20A/B88-122[»]
A/B201-433[»]
A/B457-486[»]
4DVXX-ray2.40A/B88-122[»]
A/B201-433[»]
A/B457-486[»]
4H8WX-ray1.85G43-486[»]
4I54X-ray2.50A/B43-486[»]
4JB9X-ray2.60G43-486[»]
4JDTX-ray3.26G43-486[»]
4JKPX-ray2.82G43-486[»]
4JPVX-ray2.83G43-486[»]
4JPWX-ray2.90G43-486[»]
4LSPX-ray2.15G43-486[»]
4LSQX-ray2.25G43-486[»]
4LSRX-ray2.28G43-486[»]
4LSUX-ray2.30G43-486[»]
4OLUX-ray2.20G43-122[»]
G201-303[»]
G325-486[»]
4OLVX-ray2.50G43-122[»]
G201-303[»]
G325-486[»]
4OLWX-ray2.71G43-122[»]
G201-303[»]
G325-486[»]
4OLXX-ray2.20G43-122[»]
G201-303[»]
G325-486[»]
4OLYX-ray2.35G43-122[»]
G201-303[»]
G325-486[»]
4OLZX-ray2.10G43-122[»]
G201-303[»]
G325-486[»]
4OM0X-ray2.29G43-122[»]
G201-303[»]
G325-486[»]
4OM1X-ray2.13G43-122[»]
G201-303[»]
G325-486[»]
4P9HX-ray3.00G43-122[»]
G201-303[»]
G325-486[»]
4RFNX-ray3.21A/G43-486[»]
4RFOX-ray3.20G43-486[»]
4RZ8X-ray1.90A/B/C/D43-122[»]
A/B/C/D201-303[»]
A/B/C/D325-486[»]
4XNZX-ray3.39A/D/G43-122[»]
A/D/G201-303[»]
A/D/G325-486[»]
4XVTX-ray1.69G43-486[»]
4YDJX-ray2.31G/I43-122[»]
G/I201-303[»]
G/I325-486[»]
4YDKX-ray2.05G43-122[»]
G201-303[»]
G325-486[»]
4YDLX-ray1.80A/G43-122[»]
A/G201-303[»]
A/G325-486[»]
4YFLX-ray3.39E/G43-122[»]
E/G201-303[»]
E/G325-486[»]
ModBaseiSearch...
MobiDBiSearch...

Protocols and materials databases

Structural Biology KnowledgebaseSearch...

Family and domain databases

Gene3Di2.170.40.20. 2 hits.
InterProiIPR000777. HIV1_GP160.
IPR000328. Retroviral_envelope_protein.
[Graphical view]
PfamiPF00516. GP120. 2 hits.
PF00517. GP41. 1 hit.
[Graphical view]
SUPFAMiSSF56502. SSF56502. 2 hits.
ProtoNetiSearch...

Publicationsi

  1. "Construction and characterization of HIV-1 CRF01_AE infectious molecular clones."
    Sakamoto Y., Takekawa N., Tatsumi M.
    Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE.
    Strain: 93TH057Imported.
  2. Cited for: X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF 43-122; 201-303 AND 325-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-87; ASN-236; ASN-243; ASN-264; ASN-278; ASN-291; ASN-297; ASN-335; ASN-386; ASN-392 AND ASN-442.
  3. Cited for: X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 43-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-87; ASN-160 AND ASN-188.
  4. "Increasing the potency and breadth of an HIV antibody by using structure-based rational design."
    Diskin R., Scheid J.F., Marcovecchio P.M., West A.P., Klein F., Gao H., Gnanapragasam P.N., Abadir A., Seaman M.S., Nussenzweig M.C., Bjorkman P.J.
    Science 334:1289-1293(2011) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF 43-122; 201-303 AND 325-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-87; ASN-236; ASN-264; ASN-291; ASN-297 AND ASN-386.
  5. "Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors."
    LaLonde J.M., Kwon Y.D., Jones D.M., Sun A.W., Courter J.R., Soeta T., Kobayashi T., Princiotto A.M., Wu X., Schon A., Freire E., Kwong P.D., Mascola J.R., Sodroski J., Madani N., Smith A.B.
    J. Med. Chem. 55:4382-4396(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 43-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-160 AND ASN-188.
  6. "Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops."
    Kwon Y.D., Finzi A., Wu X., Dogo-Isonagie C., Lee L.K., Moore L.R., Schmidt S.D., Stuckey J., Yang Y., Zhou T., Zhu J., Vicic D.A., Debnath A.K., Shapiro L., Bewley C.A., Mascola J.R., Sodroski J.G., Kwong P.D.
    Proc. Natl. Acad. Sci. U.S.A. 109:5663-5668(2012) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 43-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-160 AND ASN-188.
  7. "Antiviral activity and binding mode of next generation CD4-mimetics."
    Curreli F., Kwon Y.D., Zhang H, Kwong P.D., Debnath A.K.
    Submitted (FEB-2012) to the PDB data bank
    Cited for: X-RAY CRYSTALLOGRAPHY (2.49 ANGSTROMS) OF 43-122; 201-303 AND 325-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-236; ASN-243; ASN-264; ASN-278; ASN-291; ASN-297; ASN-335; ASN-356; ASN-386 AND ASN-442, X-RAY CRYSTALLOGRAPHY (2.18 ANGSTROMS) OF 43-122; 201-303 AND 325-486, GLYCOSYLATION AT ASN-236; ASN-243; ASN-264; ASN-278; ASN-291; ASN-297; ASN-335; ASN-356; ASN-386; ASN-392 AND ASN-442.
  8. "Structure-Based Design and Synthesis of an HIV-1 Entry Inhibitor Exploiting X-Ray and Thermodynamic Characterization."
    Lalonde J.M., Le-Khac M., Jones D.M., Courter J.R., Park J., Schon A., Princiotto A.M., Wu X., Mascola J.R., Freire E., Sodroski J., Madani N., Hendrickson W.A., Smith A.B.
    ACS Med. Chem. Lett. 4:338-343(2013) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 43-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-160 AND ASN-188.
  9. "Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization."
    Klein F., Diskin R., Scheid J.F., Gaebler C., Mouquet H., Georgiev I.S., Pancera M., Zhou T., Incesu R.B., Fu B.Z., Gnanapragasam P.N., Oliveira T.Y., Seaman M.S., Kwong P.D., Bjorkman P.J., Nussenzweig M.C.
    Cell 153:126-138(2013) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (2.83 ANGSTROMS) OF 43-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-160 AND ASN-188.
  10. Cited for: X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 43-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-87; ASN-160 AND ASN-188.
  11. Cited for: X-RAY CRYSTALLOGRAPHY (2.82 ANGSTROMS) OF 43-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-160 AND ASN-188.
  12. "Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody."
    Scharf L., West A.P., Gao H., Lee T., Scheid J.F., Nussenzweig M.C., Bjorkman P.J., Diskin R.
    Proc. Natl. Acad. Sci. U.S.A. 110:6049-6054(2013) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (3.26 ANGSTROMS) OF 43-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-188.
  13. Cited for: X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 43-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-160 AND ASN-188.
  14. "Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike."
    Scharf L., Scheid J.F., Lee J.H., West A.P., Chen C., Gao H., Gnanapragasam P.N., Mares R., Seaman M.S., Ward A.B., Nussenzweig M.C., Bjorkman P.J.
    Cell Rep. 7:785-795(2014) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 43-122; 201-303 AND 325-486 IN COMPLEX WITH MANNOSE, DISULFIDE BONDS, GLYCOSYLATION AT ASN-236; ASN-243; ASN-264; ASN-278; ASN-297; ASN-356 AND ASN-386.
  15. Cited for: X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 43-122; 201-303 AND 325-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-236; ASN-243; ASN-264; ASN-278; ASN-291; ASN-297; ASN-335; ASN-386; ASN-392 AND ASN-442.
  16. Cited for: X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 43-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-188.
  17. "Crystal structures of HIV-1 gp120 envelope glycoprotein in complex with NBD analogues that target the CD4-binding site."
    Kwon Y.D., LaLonde J.M., Yang Y., Elban M.A., Sugawara A., Courter J.R., Jones D.M., Smith A.B., Debnath A.K., Kwong P.D.
    PLoS ONE 9:e85940-e85940(2014) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 88-122; 201-241; 293-433 AND 457-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-236; ASN-335; ASN-356; ASN-386; ASN-392 AND ASN-442.
  18. "Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection."
    NISC Comparative Sequencing Program
    Wu X., Zhang Z., Schramm C.A., Joyce M.G., Kwon Y.D., Zhou T., Sheng Z., Zhang B., O'Dell S., McKee K., Georgiev I.S., Chuang G.Y., Longo N.S., Lynch R.M., Saunders K.O., Soto C., Srivatsan S., Yang Y.
    , Bailer R.T., Louder M.K., Mullikin J.C., Connors M., Kwong P.D., Mascola J.R., Shapiro L., Benjamin B., Blakesley R., Bouffard G., Brooks S., Coleman H., Dekhtyar M., Gregory M., Guan X., Gupta J., Han J., Hargrove A., Ho S.L., Legaspi R., Maduro Q., Masiello C., Maskeri B., McDowell J., Montemayor C., Park M., Riebow N., Schandler K., Schmidt B., Sison C., Stantripop M., Thomas J., Thomas P., Vemulapalli M., Young A.
    Cell 161:470-485(2015) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.69 ANGSTROMS) OF 43-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-236; ASN-243; ASN-264; ASN-278; ASN-386 AND ASN-392.
  19. "Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors."
    NISC Comparative Sequencing Program
    Zhou T., Lynch R.M., Chen L., Acharya P., Wu X., Doria-Rose N.A., Joyce M.G., Lingwood D., Soto C., Bailer R.T., Ernandes M.J., Kong R., Longo N.S., Louder M.K., McKee K., O'Dell S., Schmidt S.D., Tran L.
    , Yang Z., Druz A., Luongo T.S., Moquin S., Srivatsan S., Yang Y., Zhang B., Zheng A., Pancera M., Kirys T., Georgiev I.S., Gindin T., Peng H.P., Yang A.S., Mullikin J.C., Gray M.D., Stamatatos L., Burton D.R., Koff W.C., Cohen M.S., Haynes B.F., Casazza J.P., Connors M., Corti D., Lanzavecchia A., Sattentau Q.J., Weiss R.A., West A.P.Jr., Bjorkman P.J., Scheid J.F., Nussenzweig M.C., Shapiro L., Mascola J.R., Kwong P.D.
    Cell 161:1280-1292(2015) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 43-122; 201-303 AND 325-486, DISULFIDE BONDS, GLYCOSYLATION AT ASN-236; ASN-243; ASN-264; ASN-278; ASN-291; ASN-297; ASN-335; ASN-386; ASN-392 AND ASN-442.
  20. "Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity."
    Curreli F., Kwon Y.D., Zhang H., Scacalossi D., Belov D.S., Tikhonov A.A., Andreev I.A., Altieri A., Kurkin A.V., Kwong P.D., Debnath A.K.
    J. Med. Chem. 58:6909-6927(2015) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 43-122; 201-303 AND 325-486, DISULFIDE BONDS.
  21. "Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1."
    Gohain N., Tolbert W.D., Acharya P., Yu L., Liu T., Zhao P., Orlandi C., Visciano M.L., Kamin-Lewis R., Sajadi M.M., Martin L., Robinson J.E., Kwong P.D., DeVico A.L., Ray K., Lewis G.K., Pazgier M.
    J. Virol. 89:8840-8854(2015) [PubMed] [Europe PMC] [Abstract]
    Cited for: X-RAY CRYSTALLOGRAPHY (3.20 ANGSTROMS) OF 43-486, DISULFIDE BONDS.

Entry informationi

Entry nameiQ0ED31_9HIV1
AccessioniPrimary (citable) accession number: Q0ED31
Entry historyi
Integrated into UniProtKB/TrEMBL: October 17, 2006
Last sequence update: October 17, 2006
Last modified: April 13, 2016
This is version 91 of the entry and version 1 of the sequence. [Complete history]
Entry statusiUnreviewed (UniProtKB/TrEMBL)

Miscellaneousi

Keywords - Technical termi

3D-structureCombined sources

Similar proteinsi

Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:
100%UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry.
90%UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence).
50%UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster.